Results 11 to 20 of about 18,836 (198)

Pharmaceutical co-crystals of posaconazole for improvement of physicochemical properties [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2022
Posaconazole exerts an extended spectrum of antifungal activity against various strains of clinically relevant moulds and yeasts. In recent years, antifungal triazole posaconazole has become increasingly important for the prophylaxis and treatment of ...
Monika Nijhawan   +4 more
doaj   +2 more sources

Posaconazole

open access: yesJournal of Postgraduate Medicine, 2010
Posaconazole is a novel second-generation Triazole oral antifungal agent. It is highly effective in the prophylaxis of invasive fungal infections in immunocompromised patients. It is used as a first-line agent as well as for salvage therapy in invasive fungal infections including aspergillosis, oropharyngeal ...
Bhattacharya, M.   +2 more
core   +7 more sources

Posaconazole Target Attainment in Critically Ill Children: A 15‐Year Single‐Center Retrospective Analysis [PDF]

open access: yesClinical and Translational Science
Posaconazole is a triazole antifungal agent used for prophylaxis and treatment of invasive fungal diseases. Posaconazole has high inter‐individual variability in dose‐exposure relationship and benefits from therapeutic drug monitoring (TDM).
Kathryn Pavia   +2 more
doaj   +2 more sources

Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections [PDF]

open access: yesDrug Design, Development and Therapy, 2010
Emily Zoller, Connie Valente, Kyle Baker, Michael E KlepserFerris State University College of Pharmacy, Kalamazoo, Michigan, USAAbstract: Posaconazole is an extended-spectrum azole antifungal that exhibits activity against a broad range of fungal ...
Emily Zoller   +3 more
doaj   +2 more sources

Posaconazole as rescue therapy in African histoplasmosis

open access: yesBrazilian Journal of Infectious Diseases, 2013
Posaconazole Histoplasmosis Salvage therapy African histoplasmosis is a granulomatous mycosis caused by Histoplasma capsulatum var. duboisii. Treatment is usually extrapolated from guidelines for classical histoplasmosis, and includes 2-4 weeks of ...
Daniel Gonçalves   +2 more
doaj   +3 more sources

Posaconazole therapeutic drug monitoring in pediatrics: a single-center retrospective study [PDF]

open access: yesBMC Pediatrics
Background Invasive fungal infections are associated with high morbidity and mortality in immunosuppressed pediatric patients. Posaconazole is commonly used for both prophylaxis and treatment of invasive fungal infections.
Khalid W. Taher   +5 more
doaj   +2 more sources

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections

open access: yesClinical Pharmacology: Advances and Applications, 2015
Nathan P Wiederhold Departments of Pathology and Medicine/Infectious Diseases, University of Texas Health Science Center at San Antonio, South Texas Reference Laboratories, San Antonio, TX, USA Abstract: Posaconazole is a broad-spectrum triazole ...
Wiederhold NP
doaj   +1 more source

A Review of Population Pharmacokinetic Models of Posaconazole

open access: yesDrug Design, Development and Therapy, 2022
Qin Ding,1,* Shuqi Huang,1,* Zexu Sun,2 Kaifeng Chen,1 Xin Li,3 Qi Pei1 1Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Xiangya School of Pharmaceutical Sciences, Central South
Qi Pei, Shuqi Huang, Qin Ding
exaly   +2 more sources

Formation and Characterisation of Posaconazole Hydrate Form

open access: yesPharmaceuticals, 2022
Posaconazole is an API added as Form I for the production of oral suspensions, but it is found as Form-S in the final formulation. In this study, it was found that this polymorphic conversion, which may affect the bioavailability, is due to an ...
Michail Lykouras   +2 more
doaj   +2 more sources

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML [PDF]

open access: yesAntimicrobial Agents and Chemotherapy
To determine midostaurin and posaconazole plasma concentrations and investigate adverse events (AEs) resembling drug-drug interactions (DDI) when both drugs were administered concomitantly during induction chemotherapy for acute myeloid leukemia (AML ...
Carolin S. Joisten   +11 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy